Announced Wed, 29 Apr · 18:11 IST

Akums Drugs and Pharmaceuticals Limited has informed the Exchange about General Updates

Capex & Operations View source PDF

AKUMS · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.2%1-day move
₹543.50
prior close
₹542.10
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
-0.8-0.7-1.0+0.2+2.2+1.9+1.7+1.0+2.7-2.3-4.2-3.4+14.6
Up moveDown movePending
AI summary

Akums Drugs' wholly-owned subsidiary Pure and Cure Healthcare has executed a lease deed on April 28, 2026, to purchase an industrial plot of approximately 4,050 square meters with land and building. The plot is located at Plot No. 36, Sector 8A, IIE SIDCUL, Haridwar, Uttarakhand, and is adjacent to the subsidiary's existing manufacturing facility. This acquisition is intended to support the subsidiary's business operations. The specific financial terms of the lease were not disclosed in the filing.

Likely market impact

This indicates the company is expanding its manufacturing infrastructure through its subsidiary, which could support future revenue growth. The adjacent location suggests operational synergies. No immediate financial impact on shareholders unless significant capital is deployed.